ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,431.60
      -0.04%
      US Tech 100
      19,178.00
      0.57%
      Dow Jones
      38,589.16
      -0.15%
      Brent Oil
      82.275
      0.37%
      Bitcoin
      66,121.84
      -0.95%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Axsome Therapeutics Inc (AXSM)

      7. Axsome Therapeutics Inc (AXSM) News

      AXSM

      Axsome Therapeutics (AXSM)

      Axsome Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:AXSM
      DateTimeSourceHeadlineSymbolCompany
      6:07AMiHub NewswireFeaturedFifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates
      06/11/20244:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXSMAxsome Therapeutics Inc
      06/11/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXSMAxsome Therapeutics Inc
      06/05/20247:38AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXSMAxsome Therapeutics Inc
      06/05/20247:35AMGlobeNewswire Inc.Axsome Therapeutics Settles Sunosi® (solriamfetol) Patent Litigation with Unichem LaboratoriesNASDAQ:AXSMAxsome Therapeutics Inc
      06/04/20247:00AMGlobeNewswire Inc.Axsome Therapeutics Joins the American Migraine Foundation to Highlight Unmet Treatment Needs During Migraine & Headache Awareness MonthNASDAQ:AXSMAxsome Therapeutics Inc
      06/03/20247:00AMGlobeNewswire Inc.Axsome Therapeutics Supports Alzheimer’s & Brain Awareness MonthNASDAQ:AXSMAxsome Therapeutics Inc
      05/30/20247:00AMGlobeNewswire Inc.Axsome Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:AXSMAxsome Therapeutics Inc
      05/29/20248:12PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXSMAxsome Therapeutics Inc
      05/29/20248:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXSMAxsome Therapeutics Inc
      05/29/20244:24PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AXSMAxsome Therapeutics Inc
      05/29/20244:23PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AXSMAxsome Therapeutics Inc
      05/29/20247:00AMGlobeNewswire Inc.Axsome Therapeutics Highlights Data on Solriamfetol Demonstrating Improvement in Cognitive Function in Patients with Obstructive Sleep Apnea or Narcolepsy at SLEEP 2024NASDAQ:AXSMAxsome Therapeutics Inc
      05/28/20244:28PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AXSMAxsome Therapeutics Inc
      05/28/20247:00AMGlobeNewswire Inc.Axsome Therapeutics Presents Data from Multiple Programs at the 2024 American Society of Clinical Psychopharmacology Annual (ASCP) MeetingNASDAQ:AXSMAxsome Therapeutics Inc
      05/08/20247:00AMGlobeNewswire Inc.Axsome Therapeutics to Present at Upcoming Investor ConferencesNASDAQ:AXSMAxsome Therapeutics Inc
      05/06/20245:20PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AXSMAxsome Therapeutics Inc
      05/06/20248:09AMIH Market NewsIndex Futures Point to Strong Monday Opening, Building on Last Week’s Gains; Oil Prices RiseNASDAQ:AXSMAxsome Therapeutics Inc
      05/06/20247:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXSMAxsome Therapeutics Inc
      05/06/20247:00AMGlobeNewswire Inc.Axsome Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:AXSMAxsome Therapeutics Inc
      05/01/20247:00AMGlobeNewswire Inc.Axsome Therapeutics Recognizes May as Mental Health Awareness MonthNASDAQ:AXSMAxsome Therapeutics Inc
      04/15/20247:00AMGlobeNewswire Inc.Axsome Therapeutics Highlights Innovative Neuroscience Portfolio at the American Academy of Neurology (AAN) 2024 Annual MeetingNASDAQ:AXSMAxsome Therapeutics Inc
      04/10/20247:00AMGlobeNewswire Inc.Axsome Therapeutics to Report First Quarter 2024 Financial Results on May 6NASDAQ:AXSMAxsome Therapeutics Inc
      04/01/20247:00AMGlobeNewswire Inc.Axsome Therapeutics Initiates ENGAGE Phase 3 Trial of Solriamfetol for the Treatment of Binge Eating DisorderNASDAQ:AXSMAxsome Therapeutics Inc
      03/25/20247:00AMGlobeNewswire Inc.Axsome Therapeutics Announces Results of CRESCENDO Narcolepsy Patient Survey Demonstrating Unmet Needs in Treated Narcolepsy Type 1 PatientsNASDAQ:AXSMAxsome Therapeutics Inc
      03/25/20246:30AMGlobeNewswire Inc.Axsome Therapeutics Announces AXS-12 Achieves Primary Endpoint in the SYMPHONY Phase 3 Trial in NarcolepsyNASDAQ:AXSMAxsome Therapeutics Inc
      03/19/20247:00AMGlobeNewswire Inc.Axsome Therapeutics Initiates PARADIGM Phase 3 Trial of Solriamfetol for the Treatment of Major Depressive DisorderNASDAQ:AXSMAxsome Therapeutics Inc
      03/05/20247:00AMGlobeNewswire Inc.Axsome Therapeutics to Present at the Leerink Partners Global Biopharma ConferenceNASDAQ:AXSMAxsome Therapeutics Inc
      02/29/20246:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXSMAxsome Therapeutics Inc
      02/29/20246:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXSMAxsome Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:AXSM